EBioMedicine (Apr 2018)

Transcription factor 7-like 2 gene links increased in vivo insulin synthesis to type 2 diabetes

  • Sjaam Jainandunsing,
  • H. Rita Koole,
  • Joram N.I. van Miert,
  • Trinet Rietveld,
  • J.L. Darcos Wattimena,
  • Eric J.G. Sijbrands,
  • Felix W.M. de Rooij

Journal volume & issue
Vol. 30
pp. 295 – 302

Abstract

Read online

Transcription factor 7-like 2 (TCF7L2) is the main susceptibility gene for type 2 diabetes, primarily through impairing the insulin secretion by pancreatic β cells. However, the exact in vivo mechanisms remain poorly understood. We performed a family study and determined if the T risk allele of the rs7903146 in the TCF7L2 gene increases the risk of type 2 diabetes based on real-time stable isotope measurements of insulin synthesis during an Oral Glucose Tolerance Test. In addition, we performed oral minimal model (OMM) analyses to assess insulin sensitivity and β cell function indices. Compared to unaffected relatives, individuals with type 2 diabetes had lower OMM indices and a higher level of insulin synthesis. We found a T allele-dosage effect on insulin synthesis and on glucose tolerance status, therefore insulin synthesis was higher among T-allele carriers with type 2 diabetes than in wild-type individuals. These results suggest that hyperinsulinemia is not only an adaptation to insulin resistance, but also a direct cause of type 2 diabetes. Keywords: Insulin synthesis, Insulin secretion in vivo, Genetics of type 2 diabetes